Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23) (English, HTML)

View metadata and access the original English HTML file: Notice: Prescription Drug List (PDL): Multiple Additions (2021-07-23).

Format

HTML

Access

file-only

Publisher-reported update

2023-09-30

The purpose of this Notice of Amendment is to notify about the additions of the following medicinal ingredients on the Prescription Drug List (PDL) for human and veterinary use: Brexucabtagene autoleucel; Idecabtagene vicleucel; Pitolisant; Risdiplam; Selpercatinib; Solriamfetol; Tepotinib; Tildrakizumab; Trastuzumab; deruxtecan.

Access original file